XML 64 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727
Business Segments and Geographic Information
 9 Months Ended
Jun. 27, 2015
Segment Reporting [Abstract]  
Business Segments and Geographic Information
Business Segments and Geographic Information
The Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, acquisition related fair value adjustments and integration expenses, restructuring and divestiture charges and other one-time or unusual items.
Identifiable assets for the four principal operating segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its four reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues during the three and nine months ended June 27, 2015 and June 28, 2014. Segment information is as follows:
 
Three Months Ended
 
Nine Months Ended
 
June 27,
2015
 
June 28,
2014
 
June 27,
2015
 
June 28,
2014
Total revenues:
 
 
 
 
 
 
 
Diagnostics
$
306.9

 
$
293.1

 
$
907.7

 
$
869.7

Breast Health
279.5

 
238.0

 
777.1

 
703.2

GYN Surgical
85.5

 
78.5

 
248.9

 
229.4

Skeletal Health
22.0

 
23.0

 
68.5

 
67.8

 
$
693.9


$
632.6


$
2,002.2


$
1,870.1

Income from operations:
 
 
 
 
 
 
 
Diagnostics
$
30.0

 
$
4.8

 
$
85.3

 
$
24.8

Breast Health
74.7

 
58.4

 
210.7

 
128.0

GYN Surgical
9.5

 
9.1

 
27.2

 
26.8

Skeletal Health
1.8

 
3.9

 
6.2

 
8.1

 
$
116.0


$
76.2

 
$
329.4

 
$
187.7

Depreciation and amortization:
 
 
 
 
 
 
 
Diagnostics
$
88.8

 
$
95.8

 
$
269.2

 
$
282.6

Breast Health
5.9

 
11.7

 
21.8

 
30.2

GYN Surgical
25.6

 
26.3

 
77.0

 
78.4

Skeletal Health
0.3

 
0.2

 
1.1

 
0.6

 
$
120.6


$
134.0


$
369.1


$
391.8

Capital expenditures:
 
 
 
 
 
 
 
Diagnostics
$
12.4

 
$
12.8

 
$
38.6

 
$
37.9

Breast Health
2.8

 
2.7

 
8.4

 
6.8

GYN Surgical
2.2

 
2.0

 
6.6

 
5.9

Skeletal Health
0.1

 
—

 
0.3

 
0.2

Corporate
0.9

 
2.5

 
4.2

 
7.0

 
$
18.4


$
20.0


$
58.1


$
57.8

 
 
June 27,
2015
 
September 27,
2014
Identifiable assets:
 
 
 
Diagnostics
$
4,134.1

 
$
4,383.5

Breast Health
827.5

 
859.8

GYN Surgical
1,678.1

 
1,748.2

Skeletal Health
24.8

 
26.1

Corporate
1,466.0

 
1,397.1

 
$
8,130.5

 
$
8,414.7


The Company had no customers with balances greater than 10% of accounts receivable as of June 27, 2015 or September 27, 2014, or any customer that represented greater than 10% of consolidated revenues during the three and nine months ended June 27, 2015 and June 28, 2014.
The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from France, Germany and the United Kingdom. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “All others” designation includes Canada, Latin America and the Middle East.
Revenues by geography as a percentage of total revenues were as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
June 27,
2015
 
June 28,
2014
 
June 27,
2015
 
June 28,
2014
United States
77.8
%
 
75.7
%
 
75.8
%
 
74.8
%
Europe
11.3
%
 
12.5
%
 
12.2
%
 
13.9
%
Asia-Pacific
7.9
%
 
8.0
%
 
8.5
%
 
7.4
%
All others
3.0
%
 
3.8
%
 
3.5
%
 
3.9
%
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%